Moll and Ortel identified problems with the use of the prothrombin time (PT) and International Normalized Ratio (INR) for monitoring warfarin therapy in a patient with a lupus anticoagulant. Warfarin therapy in these patients should be monitored with an alternative method, since the PT may be unreliable. The authors are from Duke University.